At a glance
- Originator Hokuriku Seiyaku
- Class Antiasthmatics; Butyric acids; Small molecules; Sulfonamides
- Mechanism of Action Leukotriene D4 receptor antagonists; Thromboxane A2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 13 Mar 2001 Pharmaceutical business of BASF has been acquired by Abbott Laboratories
- 17 Aug 1998 Preclinical development for Asthma in Japan (PO)